U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H6N2O2
Molecular Weight 126.1133
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THYMINE

SMILES

CC1=CNC(=O)NC1=O

InChI

InChIKey=RWQNBRDOKXIBIV-UHFFFAOYSA-N
InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9)

HIDE SMILES / InChI

Molecular Formula C5H6N2O2
Molecular Weight 126.1133
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Biochemical characterization of uracil processing activities in the hyperthermophilic archaeon Pyrobaculum aerophilum.
2001-08-10
Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma.
2001-06-29
A stem-loop of Tetrahymena telomerase RNA distant from the template potentiates RNA folding and telomerase activity.
2001-06-19
Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor.
2001-06-15
Base sequence dependence of in vitro translesional DNA replication past a bulky lesion catalyzed by the exo- Klenow fragment of Pol I.
2001-06-05
Probing catalysis by Escherichia coli dTDP-glucose-4,6-dehydratase: identification and preliminary characterization of functional amino acid residues at the active site.
2001-06-05
Monoclonal antibody to single-stranded DNA: a potential tool for DNA repair studies.
2001-06-01
Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives.
2001-06
Structure, mechanism and engineering of a nucleotidylyltransferase as a first step toward glycorandomization.
2001-06
Crystal structures of a ddATP-, ddTTP-, ddCTP, and ddGTP- trapped ternary complex of Klentaq1: insights into nucleotide incorporation and selectivity.
2001-06
Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers.
2001-05-24
DNA repair mechanism by photolyase: electron transfer path from the photolyase catalytic cofactor FADH(-) to DNA thymine dimer.
2001-05-21
Backbone modifications of aromatic peptide nucleic acid (APNA ) monomers and their hybridization properties with DNA and RNA.
2001-05-18
Recognition and kinetics for excision of a base lesion within clustered DNA damage by the Escherichia coli proteins Fpg and Nth.
2001-05-15
Myotonic dystrophy protein kinase (DMPK) gene expression in lymphocytes of patients with myotonic dystrophy.
2001-05-10
Mutations induced by 5-formyl-2'-deoxyuridine in Escherichia coli include base substitutions that can arise from mispairs of 5-formyluracil with guanine, cytosine and thymine.
2001-05-09
Insight into the catalytic mechanism of DNA polymerase beta: structures of intermediate complexes.
2001-05-08
Aminoethylprolyl (aep) PNA: mixed purine/pyrimidine oligomers and binding orientation preferences for PNA:DNA duplex formation.
2001-05-03
Pyrrolidine nucleic acids: DNA/PNA oligomers with 2-hydroxy/aminomethyl- 4-(thymin-1-yl)pyrrolidine-N-acetic acid.
2001-05-03
Oxidative DNA damage induced by a metabolite of carcinogenic o-anisidine: enhancement of DNA damage and alteration in its sequence specificity by superoxide dismutase.
2001-05-01
An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase.
2001-05-01
Actinomycin D binds strongly to d(TGTCATTG), a single-stranded DNA devoid of GpC sites.
2001-05-01
Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation.
2001-05-01
Construction of peptide conjugates with peptide nucleic acids containing an anthracene probe and their interactions with DNA.
2001-05
Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.
2001-05
Fragmentation mechanisms of oligodeoxynucleotides: effects of replacing phosphates with methylphosphonates and thymines with other bases in T-rich sequences.
2001-05
Microuli, a family of miniature subterminal inverted-repeat transposable elements (MSITEs): transposition without terminal inverted repeats.
2001-05
Numerous gene rearrangements in the mitochondrial genome of the wallaby louse, Heterodoxus macropus (Phthiraptera).
2001-05
Role of spinal alpha1-adrenoceptor subtypes in the bladder reflex in anesthetized rats.
2001-05
Superoxide dismutases enhance H2O2-induced DNA damage and alter its site specificity.
2001-04-27
The crystal structures of psoralen cross-linked DNAs: drug-dependent formation of Holliday junctions.
2001-04-20
Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents.
2001-04-17
Binding of nucleotides to nucleoside diphosphate kinase: a calorimetric study.
2001-04-17
Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder.
2001-04-15
N(1)-C(5')-linked dimer hydrates of 5-substituted uracils produced by anodic oxidation in aqueous solution.
2001-04-06
15-mer DNA duplexes containing an abasic site are thermodynamically more stable with adjacent purines than with pyrimidines.
2001-04-03
Thymine-metal ion interactions: relevance for thymine quartet structures.
2001-04
Genotyping the -521C/T functional polymorphism in the promoter region of dopamine D4 receptor (DRD4) gene.
2001-04
Mass spectrometric evidence for mechanisms of fragmentation of charge-derivatized peptides.
2001-04
Inheritance of a stable mutation in a family with early-onset disease.
2001-04
Design and characterization of asparagine- and lysine-containing alanine-based helical peptides that bind selectively to A.T base pairs of oligonucleotides immobilized on a 27 mhz quartz crystal microbalance.
2001-03-27
Role of the Escherichia coli and human DNA glycosylases that remove 5-formyluracil from DNA in the prevention of mutations.
2001-03
The production and evaluation of antibodies for enzyme immunoassay of AZTTP.
2001-03
Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
2001-03
Rapid detection of a common dihydropyrimidine dehydrogenase mutation associated with 5-fluorouracil toxicity and congenital thymine uraciluria using fluorogenic hybridization probes.
2001-03
The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.
2001-03
Individual determination of the yield of the main UV-induced dimeric pyrimidine photoproducts in DNA suggests a high mutagenicity of CC photolesions.
2001-02-27
The eosinophil peroxidase-hydrogen peroxide-bromide system of human eosinophils generates 5-bromouracil, a mutagenic thymine analogue.
2001-02-20
Utilization of amino acids in growing kidney proximal tubule cell cultures.
2001
A novel nonsense mutation of the GTP cyclohydrolase I gene in a family with dopa-responsive dystonia.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:34:49 GMT 2025
Edited
by admin
on Mon Mar 31 17:34:49 GMT 2025
Record UNII
QR26YLT7LT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZIDOVUDINE RELATED COMPOUND C
USP-RS  
Preferred Name English
THYMINE
INCI   MI   WHO-DD  
INCI  
Official Name English
5-METHYL URACIL
Systematic Name English
THYMINE [USP IMPURITY]
Common Name English
Thymine [WHO-DD]
Common Name English
STAVUINE IMPURITY A [WHO-IP]
Common Name English
ZIDOVUDINE RELATED COMPOUND C [USP-RS]
Common Name English
THYMIN
Systematic Name English
ZIDOVUDINE IMPURITY C [WHO-IP]
Common Name English
ZIDOVUDINE IMPURITY C [EP IMPURITY]
Common Name English
ZIDOVUDINE RELATED COMPOUND C [USP IMPURITY]
Common Name English
NSC-168663
Code English
5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE (THYMINE)
Common Name English
NSC-14705
Code English
THYMINE [MI]
Common Name English
5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
Systematic Name English
Classification Tree Code System Code
LOINC 48157-2
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
LOINC 75153-7
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
LOINC 75121-4
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
NCI_THESAURUS C789
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
Code System Code Type Description
FDA UNII
QR26YLT7LT
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
MERCK INDEX
m10823
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY Merck Index
PUBCHEM
1135
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
CAS
65-71-4
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
NSC
168663
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
MESH
D013941
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-616-1
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
SMS_ID
100000091723
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
DRUG BANK
DB03462
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
NCI_THESAURUS
C881
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
RS_ITEM_NUM
1724532
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
DAILYMED
QR26YLT7LT
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
CHEBI
17821
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID4052342
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
WIKIPEDIA
THYMINE
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
RXCUI
1368871
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY RxNorm
NSC
14705
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
EVMPD
SUB27112
Created by admin on Mon Mar 31 17:34:49 GMT 2025 , Edited by admin on Mon Mar 31 17:34:49 GMT 2025
PRIMARY
Related Record Type Details
METABOLITE -> PARENT
BAIBA induces energy expenditure in adipocytes and distal fat tissues, and ?-oxidation of hepatic fatty acids in part via activation of peroxisome proliferators-activated receptor ? (PPAR?) [33]. Notably, in humans, plasma BAIBA concentrations increase with exercise and are inversely associated with metabolic risk factors.
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
Amount Not Specified
INTERNATIONAL PHARMACOPEIA
PARENT -> IMPURITY
Calculation of percentage contents: – correction factor: multiply the peak area of impurity A by 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY